知镜 Cognispect · 医学文献与研究工作台

Efficacy, safety, and tolerability of lysergic acid diethylamide for the treatment of depressive symptoms: A meta-analysis and systematic review.

Chiorean A, Kim HK, Lustig A, Husain MI.
Journal of psychopharmacology (Oxford, England) · 2026-10-30 · PMID 42960975

文献摘要

Background Since the Food and Drug Administration designated lysergic acid diethylamide (LSD) as a "breakthrough" treatment for generalized anxiety disorder, accumulating randomized clinical trials (RCTs) evaluating LSD's anxiolytic effects have also reported improved depression symptoms. Evaluating the safety and efficacy of LSD in treating depression symptoms is warranted. Methods MEDLINE/PubMED, Embase, and PsychINFO were searched from inception to December 9, 2025. RCTs evaluating efficacy of LSD on depression symptoms in adults with mental disorders were included. Cochrane Risk of Bias Tool 2.0 and χ 2 and I 2 tests measured quality and heterogeneity. This review was preregistered on PROSPERO (CRD420251063539). Results Of 465 screened studies, 5 RCTs met selection criteria ( N = 227). Our synthesis and random-effects meta-analysis demonstrated that LSD treatment significantly reduced depression symptoms compared with the comparator (unadjusted standardized mean difference = -0.69; 95% CI: -0.96 to -0.42, p = 0.0000005; adjusted standardized mean difference = -0.65; 95% CI: -0.92 to -0.38, p = 0.000002). Studies varied in design and three of the included studies administered LSD with psychological support, although study-level heterogeneity was not significant. Three studies had low risk of bias. All-cause discontinuation demonstrated reasonable acceptability of LSD treatment. Severe adverse events possibly related to study parameters included hospitalizations ( N = 3) and acute anxiety/delusions ( N = 1). Conclusion Our findings suggest that LSD, with and without psychological support, reduces depression scores in clinical populations. This review is limited by small sample size. Future well-designed RCTs are needed to establish the efficacy and safety of LSD in managing depression.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。